Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3047% below fair value
$2.77−0.07 (-2.46%)
Close on Nov 18, 2026Market cap $546.32MP/E –Yield –
Wave Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Wave Life Sciences's operating cash flow for the twelve months ending Sep 30, 2026 was -$207.05M. For fiscal 2025 it was -$187.49M. The highest annual figure on record is -$3.55M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$187.49M | – |
| FY2024 | Dec 31, 2024 | -$151.03M | – |
| FY2023 | Dec 31, 2023 | -$19.43M | – |
| FY2022 | Dec 31, 2022 | -$127.78M | – |
| FY2021 | Dec 31, 2021 | -$88.99M | – |
| FY2020 | Dec 31, 2020 | -$115.98M | – |
| FY2019 | Dec 31, 2019 | -$188.23M | – |
| FY2018 | Dec 31, 2018 | -$22.86M | – |
| FY2017 | Dec 31, 2017 | -$83.67M | – |
| FY2016 | Dec 31, 2016 | -$31.93M | – |
| FY2015 | Dec 31, 2015 | -$12.53M | – |
| FY2014 | Dec 31, 2014 | -$4.43M | – |
| FY2013 | Dec 31, 2013 | -$3.55M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$60.14M | – |
| Q2 FY2026 | Jun 30, 2026 | -$53.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$59.55M | – |
| Q4 FY2025 | Dec 31, 2025 | -$33.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$44.67M | – |
| Q2 FY2025 | Jun 30, 2025 | -$46.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$63.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$43.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$46.48M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.47M | – |
| Q1 FY2024 | Mar 31, 2024 | -$33.43M | -139.1% |
| Q4 FY2023 | Dec 31, 2023 | -$33.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$34.46M | – |
| Q2 FY2023 | Jun 30, 2023 | -$37.26M | – |
| Q1 FY2023 | Mar 31, 2023 | $85.52M | – |
| Q4 FY2022 | Dec 31, 2022 | -$33.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$25.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$28.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$44.38M | – |
| Q4 FY2020 | Dec 31, 2020 | -$31.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$20.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$38.15M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$61.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$43.68M | – |
| Q2 FY2019 | Jun 30, 2019 | -$32.93M | -146.1% |
| Q1 FY2019 | Mar 31, 2019 | -$50.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$32.82M | – |
| Q3 FY2018 | Sep 30, 2018 | -$29.01M | – |
| Q2 FY2018 | Jun 30, 2018 | $71.39M | – |
| Q1 FY2018 | Mar 31, 2018 | -$32.43M | – |
| Q4 FY2017 | Dec 31, 2017 | -$22.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$23.41M | – |
| Q2 FY2017 | Jun 30, 2017 | -$20.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$17.42M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.35M | – |
See a number that looks wrong?